m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology*; D001393:Azoles / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D002707:Chlordiazepoxide / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology*; D002951:Citrates / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004221:Disulfiram / Q000494:pharmacology*; D004336:Drug Antagonism; D004357:Drug Synergism; D007668:Kidney / Q000378:metabolism*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D008750:Methyldopa / Q000494:pharmacology*; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology*; D010672:Phenytoin / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology*; D012640:Seizures / Q000139:chemically induced*; D012701:Serotonin / Q000378:metabolism*; D013331:Strychnine / Q000494:pharmacology*; D013747:Tetrabenazine / Q000494:pharmacology*; D014293:Trimethadione / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology*; D014508:Urea / Q000494:pharmacology*
D000927:Anticonvulsants; D001393:Azoles; D002951:Citrates; D012701:Serotonin; D014443:Tyrosine; D008750:Methyldopa; D010672:Phenytoin; D004295:Dihydroxyphenylalanine; D002707:Chlordiazepoxide; D009020:Morphine; D001285:Atropine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D014508:Urea; D010293:Pargyline; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D013331:Strychnine; D014293:Trimethadione; D009526:Nialamide; D004221:Disulfiram; D002746:Chlorpromazine; D009638:Norepinephrine; D010634:Phenobarbital; D013747:Tetrabenazine